Literature DB >> 3281615

The artificial heart: infection-related morbidity and its effect on transplantation.

B P Griffith1, R L Kormos, R L Hardesty, J M Armitage, J S Dummer.   

Abstract

Between October, 1985, and September, 1987, a total of 195 patients received cardiac allografts and 15 candidates required mechanical support with the Jarvik-7 total artificial heart. Seven of the 15 died within 60 days of total artificial heart implant. There have been no late deaths, and survivors are unrestricted. Six of 7 deaths were related to infection (mediastinitis, 5; pneumonia and sepsis, 1), and the remaining 1 was due to failure of the transplanted heart. Respiratory tract infection occurred in each of the recipients who died with infection, and the same organisms appeared to be related to subsequent mediastinitis in 3 patients (Serratia marcescens, 2; Pseudomonas, 1) and caused fatal sepsis in another (Enterobacter aerogenes, Candida albicans). One patient died with pneumonia and sepsis prior to transplantation, and another succumbed with mediastinal infection known to be present before transplantation.

Entities:  

Mesh:

Year:  1988        PMID: 3281615     DOI: 10.1016/s0003-4975(98)90014-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system.

Authors:  O H Frazier; E A Rose; P McCarthy; N A Burton; A Tector; H Levin; H L Kayne; V L Poirier; K A Dasse
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

2.  Role of orthotopic heart transplantation in the management of patients with recurrent ventricular tachyarrhythmias following myocardial infarction.

Authors:  J P Bourke; A Loaiza; G Parry; C Hilton; S Furniss; J Dark; J Forty
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

3.  Artificial hearts.

Authors:  T R Graham; C T Lewis
Journal:  BMJ       Date:  1989-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.